Therapy: A big step for targeting RNAs

Nature Reviews Cancer

Volumn 10, Issue 5, 2010, Pages 313-

  Alderton, Gemma K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR 10B; ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; CALAA 01; RNA; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; CANCER TRANSPLANTATION; CLINICAL TRIAL; DRUG TARGETING; HUMAN; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RNA INTERFERENCE; SOLID TUMOR; TUMOR BIOPSY;

EID: 77951623829     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2848     Document Type: Article

References (2)

1. Davis, M. E. et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 21 Mar 2010 (doi:10.1038/nature08956)
2. Ma, L. et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nature Biotech. 28 Mar 2010 (doi:10.1038/nbt.1618)